Mpox vaccine for children under 12 wins first EU authorization after a Phase 2 trial in DRC and Uganda showed immune responses in children were 2.5 times greater than in adults. The European ...
Are we doomed if we have a bright child? No, we simply have to pay closer attention to their particular ways of navigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results